ENTITY
Cellivery Therapeutics

Cellivery Therapeutics (268600 KS)

5
Analysis
Health CareSouth Korea
Cellivery Therapeutics, Inc. operates as a pharmaceutical company. The Company develops and sells proteins drugs and other products, as well as conducts research and development activities. Cellivery Therapeutics markets its products throughout Korea.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x